| Product Code: ETC10815284 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Small Molecule CDMO Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Small Molecule CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Small Molecule CDMO Market - Industry Life Cycle |
3.4 Vietnam Small Molecule CDMO Market - Porter's Five Forces |
3.5 Vietnam Small Molecule CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Vietnam Small Molecule CDMO Market Revenues & Volume Share, By API Type, 2021 & 2031F |
3.7 Vietnam Small Molecule CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.8 Vietnam Small Molecule CDMO Market Revenues & Volume Share, By Facility Type, 2021 & 2031F |
3.9 Vietnam Small Molecule CDMO Market Revenues & Volume Share, By Regulatory Compliance, 2021 & 2031F |
4 Vietnam Small Molecule CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for small molecule drugs in the pharmaceutical industry |
4.2.2 Growth in outsourcing services by pharmaceutical companies to reduce costs and focus on core competencies |
4.2.3 Favorable government regulations and initiatives to boost the pharmaceutical sector in Vietnam |
4.3 Market Restraints |
4.3.1 Limited expertise and capabilities of local small molecule CDMO companies |
4.3.2 Lack of investment in research and development leading to lower innovation and differentiation |
5 Vietnam Small Molecule CDMO Market Trends |
6 Vietnam Small Molecule CDMO Market, By Types |
6.1 Vietnam Small Molecule CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Small Molecule CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Vietnam Small Molecule CDMO Market Revenues & Volume, By Drug Substance Development, 2021 - 2031F |
6.1.4 Vietnam Small Molecule CDMO Market Revenues & Volume, By Drug Product Manufacturing, 2021 - 2031F |
6.1.5 Vietnam Small Molecule CDMO Market Revenues & Volume, By Formulation Services, 2021 - 2031F |
6.1.6 Vietnam Small Molecule CDMO Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.7 Vietnam Small Molecule CDMO Market Revenues & Volume, By Packaging & Logistics, 2021 - 2031F |
6.2 Vietnam Small Molecule CDMO Market, By API Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Small Molecule CDMO Market Revenues & Volume, By Generic APIs, 2021 - 2031F |
6.2.3 Vietnam Small Molecule CDMO Market Revenues & Volume, By Specialty APIs, 2021 - 2031F |
6.2.4 Vietnam Small Molecule CDMO Market Revenues & Volume, By Biotech APIs, 2021 - 2031F |
6.2.5 Vietnam Small Molecule CDMO Market Revenues & Volume, By Oncology Drug APIs, 2021 - 2031F |
6.2.6 Vietnam Small Molecule CDMO Market Revenues & Volume, By High-Potency APIs, 2021 - 2031F |
6.3 Vietnam Small Molecule CDMO Market, By Drug Development Stage |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Small Molecule CDMO Market Revenues & Volume, By Early-Stage Discovery, 2021 - 2031F |
6.3.3 Vietnam Small Molecule CDMO Market Revenues & Volume, By Preclinical Trials, 2021 - 2031F |
6.3.4 Vietnam Small Molecule CDMO Market Revenues & Volume, By Clinical Trials Phase 1, 2021 - 2031F |
6.3.5 Vietnam Small Molecule CDMO Market Revenues & Volume, By Commercial Manufacturing, 2021 - 2031F |
6.3.6 Vietnam Small Molecule CDMO Market Revenues & Volume, By Post- Surveillance, 2021 - 2031F |
6.4 Vietnam Small Molecule CDMO Market, By Facility Type |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Small Molecule CDMO Market Revenues & Volume, By Pilot Scale, 2021 - 2031F |
6.4.3 Vietnam Small Molecule CDMO Market Revenues & Volume, By Large-Scale Production, 2021 - 2031F |
6.4.4 Vietnam Small Molecule CDMO Market Revenues & Volume, By R&D Facilities, 2021 - 2031F |
6.4.5 Vietnam Small Molecule CDMO Market Revenues & Volume, By Sterile Manufacturing Units, 2021 - 2031F |
6.4.6 Vietnam Small Molecule CDMO Market Revenues & Volume, By Integrated Supply Chain Management, 2021 - 2031F |
6.5 Vietnam Small Molecule CDMO Market, By Regulatory Compliance |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Small Molecule CDMO Market Revenues & Volume, By US FDA & EMA Approved, 2021 - 2031F |
6.5.3 Vietnam Small Molecule CDMO Market Revenues & Volume, By GMP & ISO 13485 Certified, 2021 - 2031F |
6.5.4 Vietnam Small Molecule CDMO Market Revenues & Volume, By WHO GMP Standards, 2021 - 2031F |
6.5.5 Vietnam Small Molecule CDMO Market Revenues & Volume, By Good Laboratory Practices, 2021 - 2031F |
6.5.6 Vietnam Small Molecule CDMO Market Revenues & Volume, By Hazardous Material Handling, 2021 - 2031F |
7 Vietnam Small Molecule CDMO Market Import-Export Trade Statistics |
7.1 Vietnam Small Molecule CDMO Market Export to Major Countries |
7.2 Vietnam Small Molecule CDMO Market Imports from Major Countries |
8 Vietnam Small Molecule CDMO Market Key Performance Indicators |
8.1 Percentage increase in the number of small molecule drug development projects outsourced to CDMOs in Vietnam |
8.2 Percentage growth in revenue of small molecule CDMO companies in Vietnam |
8.3 Number of new partnerships and collaborations formed by small molecule CDMO companies in Vietnam |
8.4 Percentage improvement in manufacturing efficiency and capacity utilization within the small molecule CDMO sector in Vietnam |
8.5 Number of regulatory approvals obtained for small molecule drug manufacturing by CDMOs in Vietnam |
9 Vietnam Small Molecule CDMO Market - Opportunity Assessment |
9.1 Vietnam Small Molecule CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Vietnam Small Molecule CDMO Market Opportunity Assessment, By API Type, 2021 & 2031F |
9.3 Vietnam Small Molecule CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
9.4 Vietnam Small Molecule CDMO Market Opportunity Assessment, By Facility Type, 2021 & 2031F |
9.5 Vietnam Small Molecule CDMO Market Opportunity Assessment, By Regulatory Compliance, 2021 & 2031F |
10 Vietnam Small Molecule CDMO Market - Competitive Landscape |
10.1 Vietnam Small Molecule CDMO Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Small Molecule CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here